Systemic Inflammation and Inhaled Corticosteroids in COPD

被引:0
作者
Antoniu, Sabina A. [1 ]
机构
[1] Gr T Popa Univ Med & Pharm, Iasi, Romania
关键词
OBSTRUCTIVE PULMONARY-DISEASE; C-REACTIVE PROTEIN; FLUTICASONE; SALMETEROL;
D O I
10.1164/ajrccm.179.2.170
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:170 / 170
页数:1
相关论文
共 4 条
  • [1] Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    Calverley, P
    Pauwels, R
    Vestbo, J
    Jones, P
    Pride, N
    Gulsvik, A
    Anderson, J
    Maden, C
    [J]. LANCET, 2003, 361 (9356) : 449 - 456
  • [2] C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease
    Dahl, Morten
    Vestbo, Jorgen
    Lange, Peter
    Bojesen, Stig E.
    Tybjaerg-Hansen, Anne
    Nordestgaard, Borge G.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2007, 175 (03) : 250 - 255
  • [3] C-reactive protein: a critical update
    Pepys, MB
    Hirschfield, GM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (12) : 1805 - 1812
  • [4] The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease
    Sin, Don D.
    Man, S. F. Paul
    Marciniuk, Darcy D.
    Ford, Gordon
    FitzGerald, Mark
    Wong, Eric
    Yorks, Ernest
    Mainra, Rajesh R.
    Ramesh, Warren
    Melenka, Lyle S.
    Wilde, Eric
    Cowie, Robert L.
    Williams, Dave
    Gan, Wen Q.
    Rousseau, Roxanne
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (11) : 1207 - 1214